Conmed Corp.
CNMD
Market Cap$1.91B
Close$
$18.20
73.2% downside
Current Fair Value
73.2% downsideOvervalued by 73.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.91 Billion |
|---|---|
| Enterprise Value | $2.86 Billion |
| Dividend Yield | $0.7975 (1.29%) |
| Earnings per Share | $2.04 |
| Beta | 0.0 |
| Outstanding Shares | 30,791,166 |
| Avg 30 Day Volume | 593,911 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 29.57 |
|---|---|
| PEG | 121.17 |
| Price to Sales | 1.7 |
| Price to Book Ratio | 2.52 |
| Enterprise Value to Revenue | 2.29 |
| Enterprise Value to EBIT | 23.68 |
| Enterprise Value to Net Income | 44 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 1.17 |
Revenue Sources
No data
ESG Score
No data
About Conmed Corp.
CEO: Curt Hartman